The exceptional result of this unique technology.

 

This unique and patented technology gives rise to a particularly cohesive monophasic gel with essential qualities.

  • Easier and faster injections without compromising the quality of the product.

  • Injections that do not require overcorrection.

Distinguished rheology.

Cohesive nature of the monophasic product.

 

Dispersive nature of the biphasic product.

 

The formation of a monoblock interdermal implant.

After 24 Hrs - Slight chronic inflammation.

 

 

 

 

 

After 4 weeks - Biointegrated implant without any secondary reaction.

 

Delayed biodegredation of the injected product.

A considerably better result is seen in the initial months in terms of increased volume and wrinkle filling.

Esthelis is distributed by Pulmon Medical www.pulmonmedical.com